Paul W. Blavin
Founder at Mercy Bioanalytics, Inc.
Profile
Paul W.
Blavin founded Mercy Bioanalytics, Inc. in 2018, where he is working as Vice Chairman from 2023.
Mr. Blavin also founded PWB Value Partners LP.
Mr. Blavin also formerly worked at Blavin & Co., Inc., as Chairman & Chief Executive Officer.
Mr. Blavin received his undergraduate degree from the University of Michigan and Masters Business Admin degree from Harvard Business School.
Paul W. Blavin active positions
| Companies | Position | Start |
|---|---|---|
Mercy Bioanalytics, Inc.
 Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Founder | 2017-12-31 |
Former positions of Paul W. Blavin
| Companies | Position | End |
|---|---|---|
| PWB Value Partners LP | Founder | - |
Blavin & Co., Inc.
 Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Chairman | - |
Training of Paul W. Blavin
| University of Michigan | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Blavin & Co., Inc.
Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Finance |
| PWB Value Partners LP | |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
- Stock Market
- Insiders
- Paul W. Blavin
